PolicyEconomic Times
OPPI DG calls for policy predictability in pharma
Positive+66
GreyOak summary
Anil Matai, OPPI DG, stated India needs predictable regulations to speed up drug approvals and boost innovation. He warned against frequent price controls under DPCO Para 19, citing China's progress in biologics. Matai emphasized shifting from generic volume to value while supporting trade margin rationalization for expensive drugs.
What it affects
- HealthcarePositive +66
Regulatory predictability needed for pharma innovation.Rolling sentiment Positive +32